Advancing Next-Generation Cell Therapy
At this year's Asia Biotech Expo,Ever-Supreme showcased its substantial R&D capabilities, ...
News Center：Media reports
-
Ever-Supreme's R&D Achievements Shin at the 2026 Asia Biotech ExpoEver-Supreme's R&D Achievements Shin at ...
BIO Asia–Taiwan 2026 was held from July 16th to 19th at the Taipei Nangang Exhibition Cent... -
Ever-Supreme's new drug CAR001 has completed Phase I safety validation and has initiated Phase IIa, targeting the global solid tumor market.Ever-Supreme's new drug CAR001 has compl...
Ever-Supreme CAR001 has successfully passed the review of the Phase I Clinical Trial Safet... -
[Ever-Supreme and China University of Chinese Medicine Hospital Join Hands for Continuous Love Delivery][Ever-Supreme and China University of Ch...
This year, Ever-Supreme once again partnered with China University of Chinese Medicine to ... -
Interview with Founder Mr. Chang-Hai TsaiInterview with Founder Mr. Chang-Hai Tsa...
Under the leadership of its founder, Mr. Chang-Hai Tsai, Ever-Supreme (6712) continues to ... -
Ever-Supreme participated in the 2025 Taiwan Neurosurgical Society Annual Meeting and the 17th First General MeetingEver-Supreme participated in the 2025 Ta...
The 2025 Annual Meeting of the Taiwan Society of Neurosurgery (TSNS) and the 17th First Ge... -
Ever-Supreme held a movie screening event on December 20th to give back to its employees, enhancing emotional connections and interaction among them, and allowing them to spend a warm time with family and friends, which can positively impact their work.Ever-Supreme held a movie screening even...
Ever-Supreme held a movie screening event on December 20th to give back to its employees. ... -
Ever-Supreme won the "2025 Modena Taiwan mRNA Foresight Innovation Award", receiving unanimous recognition from the judges.Ever-Supreme won the "2025 Modena Taiwan...
On November 28th, the Biomedical Translational Research Center (BioTReC) of Academia Sinic...